Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carey, J. O.
Right arrow Articles by Dohm, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carey, J. O.
Right arrow Articles by Dohm, G. L.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 44, Issue 6 682-688, Copyright © 1995 by American Diabetes Association


ARTICLES

Okadaic acid, vanadate, and phenylarsine oxide stimulate 2-deoxyglucose transport in insulin-resistant human skeletal muscle

JO Carey, JL Azevedo, PG Morris, WJ Pories and GL Dohm
Department of Biochemistry, East Carolina University, School of Medicine, Greenville, NC 27585, USA.

In response to insulin, several proteins are phosphorylated on tyrosine and on serine/threonine residues. Decreased phosphorylation of signaling peptides by a defective insulin receptor kinase may be a cause of insulin resistance. Accordingly, inhibition of the appropriate phosphatases might increase the phosphorylation state of these signaling peptides and thereby elicit increased glucose transport. The purpose of this study was to examine the effect of the serine/threonine phosphatase inhibitor okadaic acid and the tyrosine phosphatase inhibitors phenylarsine oxide and vanadate on 2-deoxyglucose transport in insulin-resistant human skeletal muscle. All three phosphatase inhibitors stimulated 2-deoxyglucose transport in insulin-resistant skeletal muscle. These data suggest that these compounds have bypassed a defect in at least one of the signaling pathways leading to glucose transport. Furthermore, maximal transport rates induced by the simultaneous presence of insulin and phosphatase inhibitor in insulin-resistant muscle were equal to insulin-stimulated rates in lean control subjects. However, both vanadate alone and vanadate plus insulin stimulated 2-deoxyglucose transport significantly more in insulin-sensitive tissue than in insulin-resistant tissue. These results demonstrate that although vanadate is able to stimulate glucose transport in insulin-resistant muscle, it is not able to normalize transport to the same rate achieved in insulin-sensitive muscle.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. Asante-Appiah and B. P. Kennedy
Protein tyrosine phosphatases: the quest for negative regulators of insulin action
Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E663 - E670.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Barbagallo, L. J. Dominguez, and L. M. Resnick
Insulin-Mimetic Action of Vanadate: Role of Intracellular Magnesium
Hypertension, September 1, 2001; 38(3): 701 - 704.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Korge, J. I. Goldhaber, and J. N. Weiss
Phenylarsine oxide induces mitochondrial permeability transition, hypercontracture, and cardiac cell death
Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2203 - H2213.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Cusi, S. Cukier, R. A. DeFronzo, M. Torres, F. M. Puchulu, and J. C. P. Redondo
Vanadyl Sulfate Improves Hepatic and Muscle Insulin Sensitivity in Type 2 Diabetes
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1410 - 1417.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. N. Cortright, J. L. Azevedo Jr., Q. Zhou, M. Sinha, W. J. Pories, S. I. Itani, and G. L. Dohm
Protein kinase C modulates insulin action in human skeletal muscle
Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E553 - E562.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. R. Shepherd and B. B. Kahn
Glucose Transporters and Insulin Action -- Implications for Insulin Resistance and Diabetes Mellitus
N. Engl. J. Med., July 22, 1999; 341(4): 248 - 257.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. R. Hubbard, M. Mohammadi, and J. Schlessinger
Autoregulatory Mechanisms in Protein-tyrosine Kinases
J. Biol. Chem., May 15, 1998; 273(20): 11987 - 11990.
[Full Text] [PDF]


Home page
EndocrinologyHome page
C. J. Torrance, S. J. Usala, J. E. Pessin, and G. L. Dohm
Characterization of a Low Affinity Thyroid Hormone Receptor Binding Site within the Rat GLUT4 Gene Promoter
Endocrinology, March 1, 1997; 138(3): 1215 - 1223.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. M. Rondinone and U. Smith
Okadaic Acid Exerts a Full Insulin-like Effect on Glucose Transport and Glucose Transporter 4Translocation in Human Adipocytes. EVIDENCE FOR A PHOSPHATIDYLINOSITOL 3-KINASE-INDEPENDENT PATHWAY
J. Biol. Chem., July 26, 1996; 271(30): 18148 - 18153.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1995 by the American Diabetes Association.